Ji-Rong Sun
Amgen (United States)(US)
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Angiogenesis and VEGF in Cancer, HER2/EGFR in Cancer Research, Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways
Most-Cited Works
- → Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2(2004)468 cited
- → Context-Dependent Role of Angiopoietin-1 Inhibition in the Suppression of Angiogenesis and Tumor Growth: Implications for AMG 386, an Angiopoietin-1/2–Neutralizing Peptibody(2010)148 cited
- → Molecular Pathways That Modify Tumor Radiation Response(2001)70 cited
- → NF-κB, Cytokines, Proteasomes, and Low-Dose Radiation Exposure(2002)39 cited
- → Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor(2010)37 cited
- → Lack of Differential Radiosensitization of Hypoxic Cells in a Mouse Tumor at Low Radiation Doses per Fraction by Cisplatin(1993)19 cited
- → Discovery of 2,4-bis-arylamino-1,3-pyrimidines as insulin-like growth factor-1 receptor (IGF-1R) inhibitors(2011)17 cited
- → Abstract A182: U3–1287 (AMG 888), a fully human anti-HER3 mAb, demonstrates in vitro and in vivo efficacy in the FaDu model of human squamous cell carcinoma of the head and neck (SCCHN).(2011)15 cited
- → Abstract 3090: In vivo characterization of AMG 510 - a potent and selective KRASG12Ccovalent small molecule inhibitor in preclinical KRASG12Ccancer models(2019)8 cited
- → Antagonism of Ang-Tie2 and Dll4-Notch signaling has opposing effects on tumor endothelial cell proliferation, evidenced by a new flow cytometry method(2014)7 cited